MENU
STOK
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Stoke Therapeutics (STOK) Earnings Date & Reports

A.I. Advisor
published Earnings

STOK is expected to report earnings to rise 16.76% to -53 cents per share on November 13

Stoke Therapeutics STOK Stock Earnings Reports
Q3'24
Est.
$-0.54
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.05
Q4'23
Beat
by $0.04
Q3'23
Beat
by $0.08
The last earnings report on August 07 showed earnings per share of -46 cents, beating the estimate of -54 cents. With 116.11K shares outstanding, the current market capitalization sits at 646.51M.
View a ticker or compare two or three
STOK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the research and development of treatments for genetic diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com